Drug Topics - November 19, 2007 - (Page 29) 29 a. Abdomen b. Arm c. Buttocks d. Thigh 6. Consumption of caffeinated coffee may: a. Decrease blood glucose b. Increase blood glucose c. Increase autonomic symptoms of hypoglycemia d. Decrease autonomic symptoms of hypoglycemia 7. Which of the following is a source of 15 to 20 gm a. They allow for flexibility in matching insulin to variations in diet. b. They are less expensive than conventional injections. c. They are seen as a cure for diabetes. d. They modify insulin dose to maintain euglycemia. 16. Which of the following is an advantage of the four- injection regimen in patients with Type 1 diabetes? a. This regimen decreases the need for frequent monitoring of blood glucose. b. This regimen has less risk of lipoatrophy. c. This regimen is less expensive compared with other insulin dosing regimens. d. This regimen most closely mimics the physiologic pattern of normal insulin secretion. 17. TS is a 57-year-old white male with Type 2 dia- of carbohydrates that can be used to treat an episode of hypoglycemia? a. Four to six candy bars b. Four to six hard candies c. Four to six oz of milk d. Four to six oz of soft drinks containing sugar 8. Which of the following decreases the risk of lipohy- pertrophy? a. Abstaining from alcohol consumption b. Ensuring there are no air bubbles in the syringe prior to injecting c. Rotating injection sites d. Using insulin analogs 9. Which of the following insulins could be classified betes who takes metformin 1000 mg PO BID, glyburide 10 mg PO BID, and insulin NPH 18 units SC QHS. He reports the following fasting blood sugars from the past two weeks: 199, 239, 217 145, , 219, 147 and 182. You recommend: , a. Increasing his dose of insulin NPH to 20 units SC QHS b. Increasing his dose of insulin NPH to 22 units SC QHS c. Increasing his dose of insulin NPH to 24 units SC QHS d. Increasing his dose of insulin NPH to 26 units SC QHS 18. LG was started on a regimen of three injections per as a maintenance insulin? a. Insulin aspart b. Insulin lispro c. Insulin glargine d. Insulin glulisine 10. Which of the following insulins has a cloudy ap- pearance? a. Insulin aspart b. Insulin glargine c. Insulin lispro d. Insulin NPH 11. Which of the following insulin preparations has an acidic pH that may result in more injection-site pain compared with other insulin preparations? a. Insulin aspart b. Insulin detemir c. Insulin lispro d. Insulin glargine 12. Which of the following insulins could be classified as a mealtime insulin? a. Insulin detemir b. Insulin glargine day, using 4 units of insulin aspart before breakfast, 5 units before lunch, and 8 units before dinner. He also takes 5 units of insulin NPH with his morning injection at 7:00 AM and 10 units of insulin NPH with the dinner injection at 6:00 PM. He was instructed to perform self-monitoring of blood glucose before each meal and before bedtime, and to report high or low values immediately to you at the clinic. He is calling you now to report the results of his blood glucose values for the past several days (in mg/dL): Date 7:00 AM Noon 6:00 PM 10:00 PM 5/3 226 138 62 94 5/4 197 122 71 84 5/5 240 165 68 101 5/6 219 140 70 92 LG does not report symptoms of hypoglycemia at 6:00 PM, but the values are dangerously low. Based on your understanding of insulin pharmacotherapy, which action is the best one to increase LG’s blood glucose values at 6:00 PM? a. Change injection site from the abdomen to the thigh. b. Decrease the evening insulin NPH dose by 2 units. c. Decrease the lunch insulin aspart dose by 2 units. d. Reduce the breakfast insulin aspart dose by 2 units. 19. You have now resolved the episodes of hypo- c. Insulin lispro d. Insulin NPH 13. Which of the following insulins has the most rapid onset of action? a. Insulin aspart b. Insulin glargine c. Insulin NPH d. Insulin regular 14. Which of the following statements concerning in- sulin replacement therapy is most accurate? a. Insulin therapy does not have to be monitored closely. b. Most commercial insulin products vary little with respect to time, course, and duration of hypoglycemic activity. c. Regular insulin can be administered intravenously. d. Regular insulin cannot be mixed with insulin NPH. 15. Which of the following is an advantage of insulin pumps? glycemia at 6:00 PM. Which action is the best one to
Table of Contents Feed for the Digital Edition of Drug Topics - November 19, 2007 Drug Topics - November 19, 2007 Contents Latebreakers Letters Leukemia Patients Now Have More Options First-in-Class HIV Drug Boon to Patients at End of Tether 150 Years of American Pharmacy Pharmacy Schools Confront New Pressures From Pariah to Patient ACCP Releases Position Paper on Ethical Interactions New Injectable Antibiotic Welcomed with Open Arms NCCN Updates Head and Neck Cancer Guide Improved Phosphate Binder Approved for Dialysis Patients Considering Combination Concern Ensuring Seamless Care Bill Would Create Center for Comparative Effectiveness Hospital Improves Patient Safety with Automatic Drug Distribution System Infection Rates, Patient Stays Drop with New Drug Device How R.Ph.s Helped Three Hospitals Win Quality and Safety Awards A Pharmacist and Dog in Tow are Alzheimer’s Patients’ Best Friends More PBMs Agreeing to Pricing Transparency New Insulins in the Management of Diabetes New Products Advertisers Index Classified VIEWPOINT: Reflections on Pharmacy School After 30 Years Drug Topics - November 19, 2007 Drug Topics - November 19, 2007 - Drug Topics - November 19, 2007 (Page Cover1) Drug Topics - November 19, 2007 - Drug Topics - November 19, 2007 (Page Cover2) Drug Topics - November 19, 2007 - Drug Topics - November 19, 2007 (Page 1) Drug Topics - November 19, 2007 - Contents (Page 2) Drug Topics - November 19, 2007 - Contents (Page 3) Drug Topics - November 19, 2007 - Contents (Page 4) Drug Topics - November 19, 2007 - Contents (Page 5) Drug Topics - November 19, 2007 - Latebreakers (Page 6) Drug Topics - November 19, 2007 - Latebreakers (Page 7) Drug Topics - November 19, 2007 - Leukemia Patients Now Have More Options (Page 8) Drug Topics - November 19, 2007 - Leukemia Patients Now Have More Options (Page 9A) Drug Topics - November 19, 2007 - Leukemia Patients Now Have More Options (Page 9B) Drug Topics - November 19, 2007 - Letters (Page 9) Drug Topics - November 19, 2007 - First-in-Class HIV Drug Boon to Patients at End of Tether (Page 10) Drug Topics - November 19, 2007 - First-in-Class HIV Drug Boon to Patients at End of Tether (Page 11) Drug Topics - November 19, 2007 - Pharmacy Schools Confront New Pressures (Page 12) Drug Topics - November 19, 2007 - ACCP Releases Position Paper on Ethical Interactions (Page H1) Drug Topics - November 19, 2007 - ACCP Releases Position Paper on Ethical Interactions (Page H2) Drug Topics - November 19, 2007 - ACCP Releases Position Paper on Ethical Interactions (Page H3) Drug Topics - November 19, 2007 - New Injectable Antibiotic Welcomed with Open Arms (Page H4) Drug Topics - November 19, 2007 - NCCN Updates Head and Neck Cancer Guide (Page H5) Drug Topics - November 19, 2007 - NCCN Updates Head and Neck Cancer Guide (Page H6) Drug Topics - November 19, 2007 - NCCN Updates Head and Neck Cancer Guide (Page H7) Drug Topics - November 19, 2007 - NCCN Updates Head and Neck Cancer Guide (Page H8) Drug Topics - November 19, 2007 - Improved Phosphate Binder Approved for Dialysis Patients (Page H9) Drug Topics - November 19, 2007 - Improved Phosphate Binder Approved for Dialysis Patients (Page H10) Drug Topics - November 19, 2007 - Considering Combination Concern (Page H11) Drug Topics - November 19, 2007 - Ensuring Seamless Care (Page H12) Drug Topics - November 19, 2007 - Ensuring Seamless Care (Page H13) Drug Topics - November 19, 2007 - Ensuring Seamless Care (Page H14) Drug Topics - November 19, 2007 - Ensuring Seamless Care (Page H15) Drug Topics - November 19, 2007 - Bill Would Create Center for Comparative Effectiveness (Page H16) Drug Topics - November 19, 2007 - Bill Would Create Center for Comparative Effectiveness (Page H17) Drug Topics - November 19, 2007 - Bill Would Create Center for Comparative Effectiveness (Page H18) Drug Topics - November 19, 2007 - Hospital Improves Patient Safety with Automatic Drug Distribution System (Page H19) Drug Topics - November 19, 2007 - Hospital Improves Patient Safety with Automatic Drug Distribution System (Page H20) Drug Topics - November 19, 2007 - Hospital Improves Patient Safety with Automatic Drug Distribution System (Page H21) Drug Topics - November 19, 2007 - Infection Rates, Patient Stays Drop with New Drug Device (Page H22) Drug Topics - November 19, 2007 - How R.Ph.s Helped Three Hospitals Win Quality and Safety Awards (Page H23) Drug Topics - November 19, 2007 - How R.Ph.s Helped Three Hospitals Win Quality and Safety Awards (Page H24) Drug Topics - November 19, 2007 - From Pariah to Patient (Page 13) Drug Topics - November 19, 2007 - From Pariah to Patient (Page 14) Drug Topics - November 19, 2007 - From Pariah to Patient (Page 15) Drug Topics - November 19, 2007 - From Pariah to Patient (Page 16) Drug Topics - November 19, 2007 - From Pariah to Patient (Page 17A) Drug Topics - November 19, 2007 - From Pariah to Patient (Page 17B) Drug Topics - November 19, 2007 - From Pariah to Patient (Page 17) Drug Topics - November 19, 2007 - A Pharmacist and Dog in Tow are Alzheimer’s Patients’ Best Friends (Page 18) Drug Topics - November 19, 2007 - A Pharmacist and Dog in Tow are Alzheimer’s Patients’ Best Friends (Page 19) Drug Topics - November 19, 2007 - More PBMs Agreeing to Pricing Transparency (Page 20) Drug Topics - November 19, 2007 - More PBMs Agreeing to Pricing Transparency (Page 21A) Drug Topics - November 19, 2007 - More PBMs Agreeing to Pricing Transparency (Page 21B) Drug Topics - November 19, 2007 - More PBMs Agreeing to Pricing Transparency (Page 21) Drug Topics - November 19, 2007 - New Insulins in the Management of Diabetes (Page 22) Drug Topics - November 19, 2007 - New Insulins in the Management of Diabetes (Page 23) Drug Topics - November 19, 2007 - New Insulins in the Management of Diabetes (Page 24) Drug Topics - November 19, 2007 - New Insulins in the Management of Diabetes (Page 25) Drug Topics - November 19, 2007 - New Insulins in the Management of Diabetes (Page 26) Drug Topics - November 19, 2007 - New Insulins in the Management of Diabetes (Page 27) Drug Topics - November 19, 2007 - New Insulins in the Management of Diabetes (Page 28) Drug Topics - November 19, 2007 - New Insulins in the Management of Diabetes (Page 29) Drug Topics - November 19, 2007 - New Insulins in the Management of Diabetes (Page 30) Drug Topics - November 19, 2007 - New Insulins in the Management of Diabetes (Page 31) Drug Topics - November 19, 2007 - Advertisers Index (Page 32) Drug Topics - November 19, 2007 - Classified (Page 33) Drug Topics - November 19, 2007 - Classified (Page 34) Drug Topics - November 19, 2007 - Classified (Page 35) Drug Topics - November 19, 2007 - VIEWPOINT: Reflections on Pharmacy School After 30 Years (Page 36) Drug Topics - November 19, 2007 - VIEWPOINT: Reflections on Pharmacy School After 30 Years (Page Cover3) Drug Topics - November 19, 2007 - VIEWPOINT: Reflections on Pharmacy School After 30 Years (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.